Cardiol Therapeutics Newsroom

CCORF Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsNov 21 07:31 ET

Cardiol Therapeutics Analyst Ratings

BenzingaNov 20 07:03 ET

H.C. Wainwright Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 20 06:31 ET

Cardiol Therapeutics' CardiolRx Gains Buy Rating on Positive Phase 2 Results and Strong Financial Position

TipRanksNov 20 06:27 ET

H.C. Wainwright Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsOct 24 07:31 ET

Roth MKM Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsOct 23 09:34 ET

Cardiol Therapeutics (CRDL) Gets a Buy From Roth MKM

TipRanksOct 23 08:47 ET

CCORF Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $8

Moomoo NewsOct 23 08:33 ET

Roth MKM Maintains Cardiol Therapeutics(CRDL.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 25 14:31 ET

Cardiol Therapeutics Analyst Ratings

BenzingaJun 26 08:47 ET

Cardiol Therapeutics Analyst Ratings

BenzingaJun 14 06:05 ET

HC Wainwright & Co. Reiterates Buy on Cardiol Therapeutics, Maintains $9 Price Target

BenzingaJun 14 06:05 ET

Cardiol Therapeutics Analyst Ratings

BenzingaJun 7 07:02 ET

Cardiol Therapeutics Analyst Ratings

BenzingaMay 23 07:58 ET

Analysts Conflicted on These Healthcare Names: Cardiol Therapeutics (CRDL) and MicroPort Scientific (OtherMCRPF)

TipRanksMay 14 09:35 ET

Cardiol Therapeutics Analyst Ratings

BenzingaApr 22 06:08 ET

Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Paragon 28 (FNA) and Intra-Cellular Therapies (ITCI)

TipRanksApr 5 07:05 ET

Analysts Offer Insights on Healthcare Companies: Cardiol Therapeutics (CRDL), Biogen (BIIB) and Nurix Therapeutics (NRIX)

TipRanksFeb 20 08:00 ET

Canaccord Genuity Remains a Buy on Cardiol Therapeutics (CRDL)

TipRanksNov 8, 2023 10:19 ET

Cantor Fitzgerald Reiterates Overweight on Cardiol Therapeutics, Maintains $3 Price Target

BenzingaAug 14, 2023 08:53 ET